National Health Investors (NYSE:NHI) Releases Earnings Results, Beats Estimates By $0.08 EPS

National Health Investors (NYSE:NHI) posted its quarterly earnings results on Thursday. The real estate investment trust reported $1.32 EPS for the quarter, beating the consensus estimate of $1.24 by $0.08, Zacks reports. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The business had revenue of $83.36 million during the quarter, compared to analyst estimates of $85.66 million. During the same period in the previous year, the business posted $1.03 EPS. The company’s quarterly revenue was down 1.8% on a year-over-year basis. National Health Investors updated its FY 2025 guidance to 4.880-4.91 EPS.

National Health Investors Price Performance

Shares of NYSE NHI traded up $1.66 during mid-day trading on Friday, reaching $76.97. 423,563 shares of the company traded hands, compared to its average volume of 238,050. National Health Investors has a fifty-two week low of $65.13 and a fifty-two week high of $82.32. The firm has a market cap of $3.65 billion, a PE ratio of 24.59, a price-to-earnings-growth ratio of 3.31 and a beta of 0.74. The stock has a fifty day simple moving average of $76.81 and a 200-day simple moving average of $74.36. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be issued a $0.92 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $3.68 annualized dividend and a dividend yield of 4.8%. National Health Investors’s dividend payout ratio (DPR) is 117.57%.

Institutional Trading of National Health Investors

A number of hedge funds and other institutional investors have recently modified their holdings of NHI. EverSource Wealth Advisors LLC boosted its stake in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after buying an additional 288 shares in the last quarter. NewEdge Advisors LLC lifted its holdings in National Health Investors by 28.7% in the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 345 shares during the last quarter. Osaic Holdings Inc. boosted its position in shares of National Health Investors by 24.1% during the 2nd quarter. Osaic Holdings Inc. now owns 1,629 shares of the real estate investment trust’s stock valued at $115,000 after purchasing an additional 316 shares in the last quarter. BNP Paribas Financial Markets grew its stake in shares of National Health Investors by 54.4% in the 2nd quarter. BNP Paribas Financial Markets now owns 4,334 shares of the real estate investment trust’s stock worth $304,000 after purchasing an additional 1,527 shares during the last quarter. Finally, Cetera Investment Advisers raised its holdings in shares of National Health Investors by 6.1% in the 2nd quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock worth $336,000 after purchasing an additional 275 shares in the last quarter. Institutional investors own 62.51% of the company’s stock.

Analyst Upgrades and Downgrades

NHI has been the topic of a number of recent research reports. KeyCorp raised shares of National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 target price on the stock in a report on Thursday, July 10th. Wells Fargo & Company boosted their price objective on National Health Investors from $76.00 to $80.00 and gave the company an “equal weight” rating in a research report on Wednesday, August 27th. Truist Financial increased their target price on National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a research report on Friday, August 15th. Cantor Fitzgerald began coverage on National Health Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 target price on the stock. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, National Health Investors currently has an average rating of “Buy” and a consensus target price of $84.83.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.